Small interference RNA gene therapy
View Patent ↗Gene expression is inhibited in a cell by introducing into the cell a lentiviral vector encoding a siRNA specific for the gene. Lentiviral vectors encoding siRNA specific for a cancer-associated gene inhibited expression of the gene and caused cell death after being introduced into cancer cells. Viral replication in HIV-infected cells was inhibited after introducing a lentiviral vector encoding siRNA specific for HIV genes in into the cells.
1. A composition comprising a first lentiviral vector comprising a nucleotide sequence encoding a first small interference RNA, a second lentiviral vector comprising a nucleotide sequence encoding a second small interference RNA, or a third lentiviral vector comprising a nucleotide sequence encoding a third small interference RNA, or a combination of said first, second and third lentiviral vectors, wherein each of the first, second and third small interference RNAs target a different sequence selected from the group consisting of: SEQ ID NO: 49, SEQ ID NO: 51, and SEQ ID NO: 54.
2. The composition of claim 1 , wherein the first lentiviral vector is comprised within a viral particle, the second lentiviral vector is comprised within a viral particle, and the third lentiviral vector is comprised within a viral particle.
3. The composition of claim 1 , wherein each of the first, second and third lentiviral vectors comprises a cassette comprising a promoter operably linked to the nucleotide sequence encoding the first, second and third small interference RNAs.
4. The composition of claim 3 , wherein the cassette is in a reverse orientation relative to the other genetic elements in the first, second and third lentiviral vectors.
5. The composition of claim 3 , wherein the cassette is in a forward orientation relative to the other genetic elements in the first, second and third lentiviral vectors.
6. The composition of claim 3 , wherein the promoter is in a reverse orientation as compared to the other genetic elements in the first, second and third lentiviral vectors.
7. The composition of claim 3 , wherein the promoter is a pol III promoter.
8. The composition of claim 7 , wherein the promoter comprises H1 or U6.
9. A composition comprising a lentiviral vector comprising a nucleotide sequence encoding a small interference RNA that targets a sequence selected from SEQ ID NOs: 49, 51, and 54.